Olopatadine Side Effects Olopatadine Reviews: View Olopatadine Adverse Event Reports: patient, 42 years of age, was diagnosed with dyslipidaemia and took Olopatadine Unk

Have Your experienced Olopatadine Side Effects? You are not alone. Many patients report unusual symptoms after using Olopatadine. This forum raises awareness about Olopatadine Side Effects.

side effects
Home> Olopatadine> Olopatadine Side Effects

Before Taking Olopatadine

Find Out How to Take Olopatadine

Managing Your Medicines

Tips for Taking Medicines Properly

Did You Have a Olopatadine Side Effect?

Yes, Severe
Yes, Moderate
Yes, Minor
No

How Effective is Olopatadine for You?

Exceeded Expectations
Effective
Somewhat Effective
Not Effective

Olopatadine Forum

Olopatadine Adverse Effect Reports (FDA)

Enter Unusual Symptoms or Side Effects:

Showing 1-25 of 27 

Renal Impairment (8453938-2)
on Jun 06, 2012 Male patient from JAPAN , 42 years of age, was treated with Olopatadine Hcl(View Usage). Patient experienced the following unwanted or unexpected effects: renal impairment. Olopatadine Hcl dosage: Unk.
Patient was taking other medications:

Blood Potassium Increased, Renal Disorder, Haemoglobin Decreased, Acute Respiratory Failure, Blood Creatinine Increased, Haematocrit Decreased, Blood Alkaline Phosphatase Increased, Blood Urea Increased (8389910-0)
Patient was taking Olopatadine Hcl (View Usage). Patient had the following side effects: blood potassium increased, renal disorder, haemoglobin decreased, acute respiratory failure, blood creatinine increased, haematocrit decreased, blood alkaline phosphatase increased, blood urea increased on May 08, 2012 from JAPAN Additional patient health information: Male patient , 78 years of age, . Olopatadine Hcl dosage: N/A.
Patient was taking other medications:

Toxic Skin Eruption (8385896-3)
Adverse event was reported on May 17, 2012 by a Female patient taking Olopatadine Hcl (View Usage) (Dosage: N/A) . Location: JAPAN , 69 years of age, weighting 88.18 lb, After Olopatadine was administered, patient had the following side effects: toxic skin eruption.
Patient was taking other medications:

Aggression, Suicide Attempt (8334843-9)
on Apr 23, 2012 Female patient from JAPAN , 39 years of age, was diagnosed with
  • seasonal allergy
and was treated with Olopatadine Hcl (View Usage). Patient experienced the following unwanted or unexpected effects: aggression, suicide attempt. Olopatadine Hcl dosage: Unk.
Patient was taking other medications:


Juvenile Arthritis, Hepatic Function Abnormal (8323395-5)
on Apr 27, 2012 Female patient from JAPAN , weighting 103.6 lb, was diagnosed with
  • rhinitis allergic
and was treated with Olopatadine Hcl(View Usage). Patient had the following side effects: juvenile arthritis, hepatic function abnormal. Olopatadine Hcl dosage: N/A.
Patient was taking other medications: Patient was hospitalized.

Haematocrit Increased, Leukocytosis, Chronic Myeloid Leukaemia (8125354-4)
Patient was taking Olopatadine Hcl (View Usage). After Olopatadine was administered, patient had the following side effects: haematocrit increased, leukocytosis, chronic myeloid leukaemia on Jan 30, 2012 from JAPAN Additional patient health information: Male patient , weighting 211.6 lb, was diagnosed with
  • rhinitis allergic
  • gastrooesophageal reflux disease
  • right ventricular failure
and. Olopatadine Hcl dosage: 10mg Per Day.
Patient was taking other medications:

Loss Of Consciousness, Nausea (8105502-2)
Adverse event was reported on Jan 30, 2012 by a Female patient taking Olopatadine Hcl (View Usage) (Dosage: 10 Mg, 1x/day) . Location: JAPAN , 69 years of age, Patient experienced the following unwanted or unexpected effects: loss of consciousness, nausea (nausea Questions).
Patient was taking other medications: Patient was hospitalized.

Hepatic Neoplasm Malignant, Pyrexia, Neutrophil Count Increased, Hepatic Function Abnormal, Insomnia, Hypertension, Constipation (8065380-7)
on Jan 20, 2012 Male patient from JAPAN , 54 years of age, weighting 138.9 lb, was treated with Olopatadine Hcl (View Usage). Patient had the following side effects: hepatic neoplasm malignant, pyrexia, neutrophil count increased, hepatic function abnormal, insomnia, hypertension, constipation (constipation Questions). Olopatadine Hcl dosage: Daily Dose 10 Mg.
Patient was taking other medications:

Blood Glucose Increased (8029858-4)
on Dec 27, 2011 Male patient from JAPAN , 73 years of age, weighting 154.3 lb, was treated with Olopatadine Hcl(View Usage). After Olopatadine was administered, patient had the following side effects: blood glucose increased. Olopatadine Hcl dosage: N/A.
Patient was taking other medications: Patient was hospitalized.

Blood Albumin Decreased, Aspartate Aminotransferase Increased, Blood Lactate Dehydrogenase Increased, Epstein-barr Virus Antibody Positive, Faeces Pale, Allergic Hepatitis, Prothrombin Time Prolonged, Malaise, Prothrombin Time Ratio Decreased (8018605-8)
Patient was taking Olopatadine Hcl (View Usage). Patient experienced the following unwanted or unexpected effects: blood albumin decreased, aspartate aminotransferase increased, blood lactate dehydrogenase increased, epstein-barr virus antibody positive, faeces pale, allergic hepatitis, prothrombin time prolonged, malaise, prothrombin time ratio decreased on Dec 20, 2011 from JAPAN Additional patient health information: Female patient , 81 years of age, was diagnosed with
  • pruritus
and. Olopatadine Hcl dosage: N/A.
Patient was taking other medications: Patient was hospitalized.

Laceration (8007206-3)
Adverse event was reported on Dec 13, 2011 by a Female patient taking Olopatadine Hcl (View Usage) (Dosage: 5 Mg, 2x/day) was diagnosed with
  • pruritus
and. Location: JAPAN , 71 years of age, Patient had the following side effects: laceration.
Patient was taking other medications:

Pain, Myocardial Infarction, Cerebrovascular Accident, Pulmonary Embolism, Anxiety, Gallbladder Disorder, Deep Vein Thrombosis, Cholecystitis Acute, Cholecystitis Chronic (7912392-7)
on Nov 04, 2011 Female patient from UNITED STATES , 25 years of age, weighting 135.0 lb, was treated with Olopatadine Hydrochloride (View Usage). After Olopatadine was administered, patient had the following side effects: pain (pain Questions), myocardial infarction, cerebrovascular accident, pulmonary embolism (pulmonary embolism Questions), anxiety (anxiety Questions), gallbladder disorder, deep vein thrombosis (deep vein thrombosis Questions), cholecystitis acute, cholecystitis chronic. Olopatadine Hydrochloride dosage: Unk Unk, Prn.
Patient was taking other medications:

Dyspnoea, Burning Sensation (7850789-4)
on Oct 19, 2011 Male patient from UNITED STATES , weighting 195.2 lb, was diagnosed with
  • hypersensitivity
and was treated with Olopatadine Hydrochloride(View Usage). Patient experienced the following unwanted or unexpected effects: dyspnoea, burning sensation. Olopatadine Hydrochloride dosage: N/A.
Patient was taking other medications:

Pulmonary Artery Thrombosis, Venous Thrombosis (7833499-9)
Patient was taking Olopatadine Hcl (View Usage). Patient had the following side effects: pulmonary artery thrombosis, venous thrombosis on Oct 12, 2011 from JAPAN Additional patient health information: Female patient , 29 years of age, weighting 132.3 lb, was diagnosed with and. Olopatadine Hcl dosage: 1 Tablet, As Needed.
Patient was taking other medications: Patient was hospitalized.

Jaw Disorder, Paralysis, Viith Nerve Paralysis, Apraxia, Tenderness, Cranial Nerve Palsies Multiple, Temporomandibular Joint Syndrome, Dysphagia, Trismus (7817466-7)
Adverse event was reported on Oct 03, 2011 by a Male patient taking Olopatadine Hcl (View Usage) (Dosage: N/A) . Location: JAPAN , 75 years of age, After Olopatadine was administered, patient had the following side effects: jaw disorder, paralysis (paralysis Questions), viith nerve paralysis, apraxia, tenderness, cranial nerve palsies multiple, temporomandibular joint syndrome, dysphagia, trismus.
Patient was taking other medications: Patient was hospitalized and became disabled.

Aspartate Aminotransferase Increased, Alanine Aminotransferase Increased, Hepatic Function Abnormal (7814212-8)
on Oct 04, 2011 Male patient from JAPAN , 71 years of age, weighting 160.9 lb, was treated with Olopatadine Hcl (View Usage). Patient experienced the following unwanted or unexpected effects: aspartate aminotransferase increased, alanine aminotransferase increased, hepatic function abnormal. Olopatadine Hcl dosage: N/A.
Patient was taking other medications: Patient was hospitalized.

White Blood Cell Count Increased, Haematocrit Increased (7802479-1)
on Sep 29, 2011 Male patient from JAPAN , weighting 211.6 lb, was diagnosed with
  • rhinitis allergic
  • pulmonary arterial hypertension
  • hyperuricaemia
  • right ventricular failure
  • dyslipidaemia
and was treated with Olopatadine Hcl(View Usage). Patient had the following side effects: white blood cell count increased, haematocrit increased. Olopatadine Hcl dosage: 10mg Per Day.
Patient was taking other medications:

Thyroid Cancer (7777138-4)
Patient was taking Olopatadine Hcl (View Usage). After Olopatadine was administered, patient had the following side effects: thyroid cancer (thyroid cancer Questions) on Sep 13, 2011 from JAPAN Additional patient health information: Female patient , 37 years of age, weighting 179.0 lb, . Olopatadine Hcl dosage: N/A.
Patient was taking other medications:

Dermatitis Bullous (7704364-2)
Adverse event was reported on Aug 15, 2011 by a Female patient taking Olopatadine Hcl (View Usage) (Dosage: N/A) was diagnosed with
  • hypersensitivity
  • hypertension
and. Location: JAPAN , 66 years of age, weighting 105.8 lb, Patient experienced the following unwanted or unexpected effects: dermatitis bullous.
Patient was taking other medications:

Thrombotic Cerebral Infarction, Decreased Appetite (7585927-4)
on Jun 20, 2011 Female patient from JAPAN , 77 years of age, weighting 108.0 lb, was diagnosed with
  • pruritus
and was treated with Olopatadine Hcl (View Usage). Patient had the following side effects: thrombotic cerebral infarction, decreased appetite. Olopatadine Hcl dosage: 10 Mg, Qd.
Patient was taking other medications: Patient was hospitalized.

Aspartate Aminotransferase Increased, Hypersensitivity, Alanine Aminotransferase Increased, Eczema Asteatotic, Lymphocyte Count Decreased, Blood Amylase Increased, Rash, Blood Creatinine Increased (7561801-4)
on Jun 14, 2011 Male patient from JAPAN , weighting 121.3 lb, was treated with Olopatadine(View Usage). After Olopatadine was administered, patient had the following side effects: aspartate aminotransferase increased, hypersensitivity, alanine aminotransferase increased, eczema asteatotic, lymphocyte count decreased, blood amylase increased, rash (rash Questions), blood creatinine increased. Olopatadine dosage: N/A.
Patient was taking other medications: Patient was hospitalized.

Hepatitis Acute (7554037-4)
Patient was taking Olopatadine Hcl (View Usage). Patient experienced the following unwanted or unexpected effects: hepatitis acute on Jun 14, 2011 from JAPAN Additional patient health information: Male patient , 22 years of age, . Olopatadine Hcl dosage: N/A.
Patient was taking other medications: Patient was hospitalized.

Product Formulation Issue, Bone Pain, Asthenia, Viral Infection (7357691-5)
Adverse event was reported on Jul 14, 2010 by a Male patient taking Olopatadine (View Usage) (Dosage: N/A) . Location: UNITED STATES , 54 years of age, Patient had the following side effects: product formulation issue, bone pain, asthenia, viral infection (viral infection Questions).
Patient was taking other medications:

White Blood Cell Count Increased, Pain Of Skin, Pyrexia, Mobility Decreased, Arthralgia, Hyperuricaemia, C-reactive Protein Increased, Erythrodermic Psoriasis (7315620-4)
on Feb 23, 2011 Male patient from JAPAN , 51 years of age, weighting 187.4 lb, was diagnosed with
  • dermatitis exfoliative
  • reflux oesophagitis
  • hypertension
and was treated with Olopatadine Hydrochloride (View Usage). After Olopatadine was administered, patient had the following side effects: white blood cell count increased, pain of skin, pyrexia, mobility decreased, arthralgia, hyperuricaemia, c-reactive protein increased, erythrodermic psoriasis. Olopatadine Hydrochloride dosage: N/A.
Patient was taking other medications: Patient was hospitalized.

Breast Cancer (6085275-8)
on Jan 05, 2008 Male patient from UNITED STATES , 88 years of age, weighting 160.0 lb, was diagnosed with
  • nasal congestion
and was treated with Olopatadine Hcl(View Usage). Patient experienced the following unwanted or unexpected effects: breast cancer (breast cancer Questions). Olopatadine Hcl dosage: (nasal).
Patient was taking other medications: Patient was hospitalized.

Showing 1-25 of 27 

Share Your Experience, Discuss with Others

Olopatadine Information

Alternative OLOPATADINE Names:OLOPATADI

Substance:OLOPATADI

More About Olopatadine

Side Effects reported to FDA: 27. View FDA Adverse Reports

Olopatadine safety alerts: No

Reported deaths: 2

Reported hospitalizations: 12

Ask a Doctor


13 Doctors are Online Now. Current Wait time: 7 Minutes

View Olopatadine Use Reports

What do You think about Olopatadine? Join the discussion!

blog comments powered by Disqus

Medicines have benefits and risks. The risks are the chances that something unwanted or unexpected could happen to you when you use them. You can protect yourself by searching summaries of recent safety Olopatadine alerts and medication adverse reports. Search for documented Olopatadine side effects on the label or the drug's package insert. You may also want to speak with your pharmacist or healthcare provider. Sometimes there are risks that only come to light after a medical product gets on the market and is used in a larger number of patients, for a longer period of time, and in patients whose health characteristics are different from those of the patients studied before approval.

Go to the top of the page
further research and contacting my doctor

When did you start feeling unusual symptoms? what was the first symptom? Did your symptoms get worse over time? Did you have similar symptoms before using Olopatadine? What did Your doctor say? Share Your Story

> Medical Devices

Reply to Olopatadine Questions, Answers, Feedback and Comments

No comments have been provided.

Olopatadine Adverse Reactions
Aspartate Aminotransferase Increased ( 3 Reports)
Hepatic Function Abnormal ( 3 Reports)
Alanine Aminotransferase Increased ( 2 Reports)
Arrhythmia ( 2 Reports) Arrhythmia Questions
Blood Creatinine Increased ( 2 Reports)
Blood Pressure Decreased ( 2 Reports)
Bradycardia ( 2 Reports)
Cardiac Arrest ( 2 Reports) Cardiac arrest Questions
Circulatory Collapse ( 2 Reports)
Dizziness ( 2 Reports) Dizziness Questions
Haematocrit Increased ( 2 Reports)
Malaise ( 2 Reports)
Pyrexia ( 2 Reports)
White Blood Cell Count Increased ( 2 Reports)
Acute Respiratory Failure ( 1 Reports)
Aggression ( 1 Reports)
Allergic Hepatitis ( 1 Reports)
Anxiety ( 1 Reports) Anxiety Questions
Apraxia ( 1 Reports)
Arthralgia ( 1 Reports)
Asthenia ( 1 Reports)
Autonomic Neuropathy ( 1 Reports)
Blood Albumin Decreased ( 1 Reports)
Blood Alkaline Phosphatase Increased ( 1 Reports)
Blood Amylase Increased ( 1 Reports)
Blood Glucose Increased ( 1 Reports)
Blood Lactate Dehydrogenase Increased ( 1 Reports)
Blood Potassium Increased ( 1 Reports)
Blood Urea Increased ( 1 Reports)
Bone Pain ( 1 Reports)

Often additional risks of using a medication, such as Olopatadine, become known after product is used by a larger number of patients, for a longer period of time, and by patients with different health characteristics from those studied before drug approval. This page allows You to Find answers and discuss health symptoms with other Olopatadine users, Learn more about unwanted side effects & find ways to reduce them. Browse Olopatadine Adverse Reports reported to FDA and participate in Olopatadine discussion, find alternative treatments and find ways to avoid or reduce risks associated with using Olopatadine. You can also Post a question to users community or Ask a Doctor. PatientsVille.com is Your Complete Guide to all common, undocumented and undisclosed side effects associated with drugs and vaccines.

Be aware of the following potential Olopatadine risks:

  • Watch for any Serious adverse events, such as life-threatening situation, which can require an admission to hospital or longer-than-expected hospital stay, permanent disability, birth defect, miscarriage, stillbirth, or birth with serious disease requires medical care to prevent permanent damage
  • Any potential Olopatadine quality problem: suspected counterfeit product, potentially contaminated product indicated by suspicious odor or unusual color, inaccurate or unreadable product labeling
  • Potential Olopatadine use error: mixing up products with similar drug names or packaging, taking wrong dose of a drug because of confusing dosing instructions on label
  • When applicable, Problems with different manufacturer of same medicine: not getting same results from a generic drug as a brand name drug, or from another generic

side effects
Olopatadine Side Effects Notice - The material on this site is for informational purposes only, and is not a substitute for medical advice, diagnosis or treatment provided by a qualified health care provider. PatientsVille.com does not provide medical advice, diagnosis or treatment. The information regarding Olopatadine adverse reports, reviews and polls contained on PatientsVille.com site has not been scientifically or otherwise verified as to a cause and effect relationship and cannot be used to estimate the incidence of adverse drug reactions or for establishing or changing of patient treatments. Thank you for visiting Patientsville.com!